InCephalo Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

InCephalo General Information

Description

Developer of compartment-locked biologic therapies designed to treat central nervous system disorders and brain cancers. The company utilizes antibody and biologic engineering technology that binds therapeutic molecules locally within the central nervous system compartment to minimize systemic exposure, optimize drug half-life, reduce peripheral side effects, and improve therapeutic delivery, enabling healthcare providers and pharmaceutical partners to deliver safe and targeted oncology treatments directly to affected brain tissues.

Contact Information

Website
www.incephalo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hegenheimermattweg 167 A
  • 4123 Allschwil
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Hegenheimermattweg 167 A
  • 4123 Allschwil
  • Switzerland

InCephalo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InCephalo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Dec-2023 Completed Clinical Trials - General
6. Grant 09-Oct-2023 Completed Clinical Trials - General
5. Early Stage VC 01-Sep-2022 Completed Clinical Trials - General
4. Grant 23-Jun-2022 Completed Startup
3. Accelerator/Incubator 28-Jun-2021 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view InCephalo’s complete valuation and funding history, request access »

InCephalo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InCephalo Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gold Track Accelerator/Incubator
Eurostars Other Minority
High-Tech Gründerfonds Venture Capital Minority
LifeLink Ventures Venture Capital Minority
UZH Lifesciences Fund Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

InCephalo FAQs

  • When was InCephalo founded?

    InCephalo was founded in 2021.

  • Where is InCephalo headquartered?

    InCephalo is headquartered in Allschwil, Switzerland.

  • What is the size of InCephalo?

    InCephalo has 10 total employees.

  • What industry is InCephalo in?

    InCephalo’s primary industry is Drug Discovery.

  • Is InCephalo a private or public company?

    InCephalo is a Private company.

  • What is InCephalo’s current revenue?

    The current revenue for InCephalo is .

  • How much funding has InCephalo raised over time?

    InCephalo has raised $500K.

  • Who are InCephalo’s investors?

    Gold Track, Eurostars, High-Tech Gründerfonds, LifeLink Ventures, and UZH Lifesciences Fund are 5 of 9 investors who have invested in InCephalo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process